| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Thursday, April 07, 2022 5:14:01 PM
Great....now they should try doing an actual valid clinical trial instead of blowing smoke in useless pr's that arent worth squat.
You come on here rambling on about the same garbage every time when its clear to all you know nothing.
Like I said, keep at it....youre good for a few laughs.
You come on here rambling on about the same garbage every time when its clear to all you know nothing.
Like I said, keep at it....youre good for a few laughs.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
